Eating Disorder Clinics in European Union 2026: Industry Statistics & Trends

The Eating Disorder Clinics industry in the European Union consists of specialized psychiatric and behavioral healthcare facilities providing inpatient, residential, and day-treatment services for conditions such as anorexia nervosa, bulimia nervosa, and binge eating disorder. The sector is experiencing structural expansion driven by rising diagnostic rates and public health initiatives following the post-pandemic surge in adolescent mental health cases. According to the latest available epidemiological data published in a 2024 European healthcare model study, Germany led major EU markets with approximately 75,000 diagnosed prevalent cases of anorexia nervosa in 2023, followed by Spain with

Industry snapshot

Key public data points

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

What does the Eating Disorder Clinics in European Union industry cover?

The eating disorder clinics industry encompasses dedicated medical and psychological facilities providing structured interventions for patients suffering from severe feeding and eating disorders. These services are delivered across a continuum of care that includes acute inpatient hospitalization, residential rehab units, partial hospitalization (day care), and intensive outpatient programs. Treatment regimens combine medical stabilization, psychiatric care, nutritional rehabilitation, and specialized psychological modalities such as Cognitive Behavioral Therapy (CBT-E) and family-based treatment.

• •Facilities treat official pathologies classified under the F50 code block of the International Classification of Diseases (ICD-10/ICD-11).
• •Scope ranges from high-dependency medical stabilization units to specialized step-down residential recovery homes.
• •Care models are highly multidisciplinary, requiring simultaneous staffing of psychiatrists, specialized dietitians, pediatricians, and clinical psychologists.

Who operates in the industry and how is it structured?

The European Union's market structure is highly fragmented and split between state-funded public health systems, non-profit foundations, and private corporate healthcare providers. National healthcare systems, such as the single-payer frameworks in southern Europe or the statutory health insurance model (Gesetzliche Krankenversicherung) in Germany, fund the majority of clinical pathways. Private operators often cater to gaps in state capacity, providing specialized tertiary care and attracting self-pay or private-insurance clients.

• •Publicly funded beds face severe capacity constraints, leading to a reliance on private contract providers to fulfill state care mandates.
• •The market features local specialized entities alongside a growing presence of multinational behavioral health groups.
• •Day-treatment clinics have expanded significantly to mitigate the high operational costs associated with full-time residential stays.

What drives demand in the industry?

Demand for clinical eating disorder services is driven by an increase in diagnosed prevalence, particularly among adolescent and young adult demographics across the EU. Social pressures, changes in digital media consumption, and the long-term psychological impacts of social isolation have compounded underlying vulnerability factors. Furthermore, health tracking and clinical outreach models have led to earlier detection, shifting demand toward specialized clinics capable of rapid intervention.

• •Official data demonstrates a heavy gender disparity, with females accounting for approximately 92% of the total diagnosed prevalent cases of anorexia nervosa in Europe in 2023.
• •A 2024 economic care-pathway study across EU nations noted that expanding early intervention models could reduce downstream long-term hospitalization costs by more than 50%.
• •The implementation of screening tools like the SCOFF questionnaire in primary care settings has substantially increased formal clinical referrals to secondary psychiatric centers.

Who are the notable companies in the industry?

The competitive landscape in the EU includes specialized private medical groups, regional hospital operators, and multinational behavioral health companies. These operators scale their networks by integrating eating disorder pathways within broader mental health portfolios or establishing highly specialized standalone brands. Well-established European and international providers operate extensive residential and outpatient clinics across multiple Member States.

• •Schoen Clinic (Schön Klinik SE), a major German-headquartered private hospital group, operates highly specialized eating disorder programs across Germany and neighboring European regions.
• •Cygnet Health Care (a subsidiary of Universal Health Services, Inc.) is active in behavioral health delivery and runs specialized tertiary units treating complex eating disorders.
• •Changes GGZ is an established behavioral healthcare group in mainland Europe operating specialized residential facilities for adolescents and young adults.
• •Korian (Clariane SE), a European healthcare and nursing provider, delivers specialized psychiatric and clinical rehabilitation services through its extensive clinic network.

What are the recent trends and outlook?

The industry is trending toward hybrid care pathways that blend intensive residential stays with digital outpatient step-down support. Providers are focusing on specialized age-specific protocols, particularly for children under 14, where clinical presentations have shifted in severity. The long-term outlook focuses heavily on reducing inpatient bed days through early-intervention frameworks and specialized day-patient infrastructure.

• •Clinics are increasingly adopting device-assisted protocols, such as the Mandometer method utilized in Sweden, to track and retrain physiological eating behaviors.
• •Resource allocation is pivoting toward specialized caregiver training programs to support family-centric home treatments following clinical discharge.
• •Clinical research inside EU university hospitals is exploring novel interventions, including transcutaneous vagus nerve stimulation and targeted psychopharmacology, to address chronic cases.

How is the industry regulated?

Operators of eating disorder clinics within the European Union must navigate rigorous national and regional healthcare regulations. Facilities are subject to strict clinical governance, staffing-ratio mandates, and infrastructure inspections enforced by national health ministries or independent statutory bodies. Furthermore, diagnostic coding standards and data collection must comply strictly with pan-European data privacy laws and updated healthcare reporting revisions.

• •All clinical and personal patient data collected during treatment must strictly abide by the General Data Protection Regulation (GDPR) standards across the EU.
• •Clinics must continually adjust their reporting metrics to match the diagnostic updates implemented in the official ICD-10-CM and upcoming ICD-11 registries.
• •Facilities operating in specific Member States require formal certification, such as ISO 9001 quality management standards or specific national accreditation from bodies like the Haute Autorité de Santé (HAS) in France.

Government, statistical and trade sources used for this Claight analysis.

• Cambridge Core European Psychiatry: Quantifying the economic value of earlier and enhanced management of anorexia nervosa 2024 ·
• World Health Organization (WHO) International Classification of Diseases Registry ·
• DelveInsight Anorexia Nervosa Epidemiology and Market Forecast 2034 (Published 2024) ·
• European Commission NACE Rev. 2 Statistical Classification of Economic Activities